The Long-Term Care Data Cooperative is an NIA-funded collection of nursing-home and assisted-living health records built for research. In 2026 it supports dementia study design and trials, but it does not measure daily life for family caregivers at home. According to the AHCA/NCAL press release describing the resource, the Cooperative is provider-led and governed by AHCA/NCAL with Brown University, Hebrew SeniorLife and NYU. For families, the question is practical: what can facility records show about care, and what remains unseen?.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What records does the Cooperative hold?
- How do researchers use it for dementia in 2026?
- How strong is the data for study design?
- Why does facility data miss home caregiving?
- Why does this research matter for families now?
What records does the Cooperative hold?
The Cooperative's official site says it gathers residents' electronic health records from major long-term-care vendors. It links those records to Medicare claims through the NIA Data LINKAGE Program for approved study in a secure cloud. The founding JAMDA article from 2022 sets four purposes for the data.
Those purposes shape which dementia questions the records can address. A study might compare blood-pressure control across homes using vitals and medication fields. A trial team might use stay and discharge fields to find eligible residents and track outcomes.
- health-care operations and population analytics
- public-health surveillance
- observational comparative-effectiveness research
- recruitment and outcome measurement for pragmatic and embedded dementia trials
How do researchers use it for dementia in 2026?
The 2026 NIA summit report on dementia care and caregiving research names the Cooperative alongside NHATS/NSOC and LINKAGE as key infrastructure. It points to more robust longitudinal study of functioning, health outcomes and caregiving. Longitudinal means following the same residents over months and moves.
A transfer from assisted living to skilled nursing can appear as linked stays and claims rather than a single snapshot. For embedded dementia trials, teams can recruit inside participating homes and measure outcomes from routine records. That design lowers extra visits and keeps study care closer to usual care.
How strong is the data for study design?
A February 2026 Journal of the American Geriatrics Society study tested 2023 skilled-nursing residents and facilities against national data. The IMPACT Collaboratory summary of the validation work described the Cooperative as a robust long-term-care research resource. The authors checked completeness of stay, discharge, vitals, glucose and medication records.
Complete fields help researchers define study entry, track change and compare treatments across homes. The RTI Health Solutions characterization covered 793 nursing homes in 28 states and 293,605 residents admitted since 2019. Its focus was lag times and novel electronic-record elements, not direct caregiver-reported burden.
Why does facility data miss home caregiving?
The 2026 NIA report notes that data siloes and access barriers persist. Its findings describe facility care, while unpaid care at home and full care-partner outcomes remain outside facility records. Facility files track what staff record during a stay. They do not track home hours, care-partner health or costs outside the stay.
A daughter's nightly supervision may never appear in vitals or discharge codes. A spouse's lost earnings do not sit in a medication table. Use Cooperative findings for what they show about facility care and trial outcomes. Look to caregiver surveys and cost studies for the home side of dementia.
- hours of unpaid help, lost work time and out-of-pocket strain
- sleep, worry and health changes in the care partner
- care given before admission or after discharge
Why does this research matter for families now?
According to the Alzheimer's and Dementia cost study, 5.7 million adults live with dementia supported by 5.2 million care partners. The same study put total 2026 costs at $818 billion, driven heavily by unpaid care and lost earnings.
Large unpaid costs explain why better facility evidence alone cannot settle family decisions. Trial and surveillance findings need pairing with home-care measures and support planning.
You Might Also Like
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: Study Design and Evidence Limits for Family Caregivers
- NHATS and NSOC Dementia Care Data Priorities in 2026: Study Design and Evidence Limits for Family Caregivers
- Electronic Health Records for Dementia Care Research in 2026: Study Design and Evidence Limits for Family Caregivers
